Company is broadening its monitoring services to include devices, nutritional supplements and 'designer drugs'
In the ongoing trench warfare between regulatory bodies, legitimate online healthcare-products activity and illegal or illicit online pharmacies, LegitScript (Portland, OR) says it has scored a significant victory recently: shutting down MyRxCash.com, a pharmacy affiliate-marketing portal. This “anchor” site, as LegitScript president John Horton calls it, was connected to hundreds of other websites that had used its templates and other back-end services to sell pharmaceuticals online without prescriptions. Affiliates could earn upwards of 40% commissions on their sales.
"This website was like a proverbial 'mothership' that spawned hundreds of unlicensed, unregulated rogue online pharmacies selling prescription-only medicines to patients, thus putting their health and safety at risk," Horton says. To effect the shutdown, LegitScript works with the major search engines (to which it is a contractor) and Internet domain-name providers to reject advertising and hosting services. These companies, in turn, are beholden to the US Dept. of Justice and many international regulatory agencies to police their own operations so as not to support illicit online activity. (Famously, Google paid a $500-million fine to DoJ in 2011 for its lax enforcement at that time.)
Horton says that it has been involved in the shutdown of 15,000 rogue pharmacies during this calendar year; it was also a participant in the international Operation Pangea V, which coordinated FDA, DoJ, Interpol and other enforcement agencies in shutting down illegal online pharmacies and confiscating counterfeit products. But the task is Sisyphean: new sites crop up routinely, and the cat-and-mouse game goes on.
Horton says that the company works primarily with these agencies and with the Internet service providers, but it also offers brand and product-monitoring services to the pharma industry. There is a sort of cross-endorsement relationship between it and the National Assn. of Boards of Pharmacy (NABP; Mt. Prospect, IL), which sponsors the Verified Internet Pharmacy Practice Sites (VIPPS), used by many legitimate online pharmacies. The company is about to launch a significant expansion of its services to include medical devices, nutritional supplements and “designer drugs” (synthetic products that, by subtly altering their chemistry, can avoid patents while still producing psychoactive effects)—a new worry for drug enforcement agencies.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.